The combined results from our meta-analysis indicated that both of these IL7RA polymorphisms were associated with increasing MS risk with high statistical power; this finding is well-matched with the conclusions of two individual studies investigated by Zhang et al. 23 and Lundmark et al. 22. The gene discussed is IL7R; the disease is myeloid sarcoma.